Topics

FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic

10:33 EDT 3 Oct 2019 | FDA

FDA approved Descovy in at-risk adults and adolescents for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex.

Original Article: FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic

NEXT ARTICLE

More From BioPortfolio on "FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...